- Home
- ASRT vs ANVS Comparison
ASRT vs ANVS Comparison
Compare ASRT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- ANVS
- Stock Information
- Founded
- ASRT 1995
- ANVS 2008
- Country
- ASRT United States
- ANVS United States
- Employees
- ASRT N/A
- ANVS N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- ASRT Health Care
- ANVS Health Care
- Exchange
- ASRT Nasdaq
- ANVS Nasdaq
- Market Cap
- ASRT 57.9M
- ANVS 44.6M
- IPO Year
- ASRT 1997
- ANVS 2020
- Fundamental
- Price
- ASRT $0.69
- ANVS $2.86
- Analyst Decision
- ASRT Strong Buy
- ANVS Strong Buy
- Analyst Count
- ASRT 2
- ANVS 4
- Target Price
- ASRT $3.25
- ANVS $18.00
- AVG Volume (30 Days)
- ASRT 237.6K
- ANVS 433.6K
- Earning Date
- ASRT 08-06-2025
- ANVS 08-14-2025
- Dividend Yield
- ASRT N/A
- ANVS N/A
- EPS Growth
- ASRT N/A
- ANVS N/A
- EPS
- ASRT N/A
- ANVS N/A
- Revenue
- ASRT $119,001,000.00
- ANVS N/A
- Revenue This Year
- ASRT N/A
- ANVS N/A
- Revenue Next Year
- ASRT $11.91
- ANVS N/A
- P/E Ratio
- ASRT N/A
- ANVS N/A
- Revenue Growth
- ASRT N/A
- ANVS N/A
- 52 Week Low
- ASRT $0.51
- ANVS $1.11
- 52 Week High
- ASRT $1.80
- ANVS $13.91
- Technical
- Relative Strength Index (RSI)
- ASRT 56.38
- ANVS 57.81
- Support Level
- ASRT $0.63
- ANVS $2.24
- Resistance Level
- ASRT $0.73
- ANVS $2.97
- Average True Range (ATR)
- ASRT 0.03
- ANVS 0.26
- MACD
- ASRT 0.01
- ANVS 0.02
- Stochastic Oscillator
- ASRT 59.73
- ANVS 65.58
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.